183 related articles for article (PubMed ID: 8049634)
41. Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light.
Wheeler LA; Saperstein MD; Lowe NJ
J Invest Dermatol; 1981 Aug; 77(2):181-5. PubMed ID: 7276613
[TBL] [Abstract][Full Text] [Related]
42. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars.
Jongeneelen FJ; Scheepers PT; Groenendijk A; Van Aerts LA; Anzion RB; Bos RP; Veenstra SJ
Am Ind Hyg Assoc J; 1988 Dec; 49(12):600-7. PubMed ID: 3213813
[TBL] [Abstract][Full Text] [Related]
43. 1-Hydroxypyrene as an indicator of the mutagenicity of coal tar after activation with human liver preparations.
Jongeneelen FJ; vd Akker W; Bos RP; Anzion RB; Theuws JL; Roelofs HM; Henderson PT
Mutat Res; 1988 Feb; 204(2):195-201. PubMed ID: 3278210
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the relationship between PAH content and mutagenic activity of fumes from roofing and paving asphalts and coal tar pitch.
Machado ML; Beatty PW; Fetzer JC; Glickman AH; McGinnis EL
Fundam Appl Toxicol; 1993 Nov; 21(4):492-9. PubMed ID: 8253302
[TBL] [Abstract][Full Text] [Related]
45. 1-hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product.
Jongeneelen FJ; Anzion RB; Leijdekkers CM; Bos RP; Henderson PT
Int Arch Occup Environ Health; 1985; 57(1):47-55. PubMed ID: 4077281
[TBL] [Abstract][Full Text] [Related]
46. [Mutagenic activity of urine of patients with psoriasis treated with pharmaceutical black coal tar].
Gardosová D; Kalina I; Hejj F; Mezencevová V; Salagovic J; Némethová G
Cas Lek Cesk; 1994 Aug; 133(15):463-6. PubMed ID: 8082111
[TBL] [Abstract][Full Text] [Related]
47. Methods for routine biological monitoring of carcinogenic PAH-mixtures.
Jongeneelen FJ
Sci Total Environ; 1997 Jun; 199(1-2):141-9. PubMed ID: 9200857
[TBL] [Abstract][Full Text] [Related]
48. Levels of 1-hydroxypyrene in urine of people living in an oil producing region of the Andean Amazon (Ecuador and Peru).
Webb J; Coomes OT; Mergler D; Ross NA
Int Arch Occup Environ Health; 2018 Jan; 91(1):105-115. PubMed ID: 28939924
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of the usefulness of 2-hydroxypyrene determination in urine and other possible tests for determining exposure to polycyclic aromatic hydrocarbons].
Brzeźnicki S; Jakubowski M
Med Pr; 1993; 44(4):355-62. PubMed ID: 8255215
[TBL] [Abstract][Full Text] [Related]
50. Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons.
Jongeneelen FJ; van Leeuwen FE; Oosterink S; Anzion RB; van der Loop F; Bos RP; van Veen HG
Br J Ind Med; 1990 Jul; 47(7):454-61. PubMed ID: 2383514
[TBL] [Abstract][Full Text] [Related]
51. Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens.
Jongeneelen FJ
Int Arch Occup Environ Health; 1992; 63(8):511-6. PubMed ID: 1587624
[TBL] [Abstract][Full Text] [Related]
52. A rapid and simple method for the analysis of 1-hydroxypyrene glucuronide: a potential biomarker for polycyclic aromatic hydrocarbon exposure.
Singh R; Tucek M; Maxa K; Tenglerová J; Weyand EH
Carcinogenesis; 1995 Dec; 16(12):2909-15. PubMed ID: 8603463
[TBL] [Abstract][Full Text] [Related]
53. Exposure to polycyclic aromatic hydrocarbons in coal liquefaction workers: impact of a workwear policy on excretion of urinary 1-hydroxypyrene.
Quinlan R; Kowalczyk G; Gardiner K; Calvert I
Occup Environ Med; 1995 Sep; 52(9):600-5. PubMed ID: 7550800
[TBL] [Abstract][Full Text] [Related]
54. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of workers exposed to coal tar pitch volatiles in an anode plant.
Venier P; Clonfero E; Cottica D; Gava C; Zordan M; Pozzoli L; Levis AG
Carcinogenesis; 1985 May; 6(5):749-52. PubMed ID: 4006058
[TBL] [Abstract][Full Text] [Related]
55. [Analysis of polynuclear aromatic hydrocarbons in kitchen and determination of urinary 1-hydroxypyrene of cooks].
Zhao ZH
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Jul; 26(4):193-6. PubMed ID: 1302188
[TBL] [Abstract][Full Text] [Related]
56. Nonselective and selective methods for biological monitoring of exposure to coal-tar products.
Bos RP; Jongeneelen FJ
IARC Sci Publ; 1988; (89):389-95. PubMed ID: 3198226
[TBL] [Abstract][Full Text] [Related]
57. Urinary 1-hydroxypyrene: a biomarker for polycyclic aromatic hydrocarbon exposure in coal liquefaction workers.
Quinlan R; Kowalczyk G; Gardiner K; Hale K; Walton S; Calvert I
Occup Med (Lond); 1995 Apr; 45(2):63-8. PubMed ID: 7718821
[TBL] [Abstract][Full Text] [Related]
58. Polycyclic aromatic hydrocarbon exposure, urinary mutagenicity, and DNA adducts in rubber manufacturing workers.
Peters S; Talaska G; Jönsson BA; Kromhout H; Vermeulen R
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1452-9. PubMed ID: 18559561
[TBL] [Abstract][Full Text] [Related]
59. Urinary and biliary excretion kinetics of 1-hydroxypyrene following intravenous and oral administration of pyrene in rats.
Bouchard M; Viau C
Toxicology; 1998 May; 127(1-3):69-84. PubMed ID: 9699795
[TBL] [Abstract][Full Text] [Related]
60. Urinary 1-hydroxypyrene as an indicator of human exposure to ambient polycyclic aromatic hydrocarbons in a coal-burning environment.
Zhao ZH; Quan WY; Tian DH
Sci Total Environ; 1990 Mar; 92():145-54. PubMed ID: 2326620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
